3//SEC Filing
Qiming U.S. Healthcare Fund II, L.P. 3
Accession 0001209191-21-043119
CIK 0001783032other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:16 PM ET
Size
7.7 KB
Accession
0001209191-21-043119
Insider Transaction Report
Form 3
Qiming U.S. Healthcare Fund II, L.P.
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (401,065 underlying)Series A Preferred Stock
→ Common Stock (1,656,577 underlying)
Qiming U.S. Healthcare GP II, LLC
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (401,065 underlying)Series A Preferred Stock
→ Common Stock (1,656,577 underlying)
Footnotes (2)
- [F1]The shares of the Issuer's Preferred Stock will automatically convert on a 4.225582-for-one basis into the number of shares of the issuer's Common Stock shown in column 3 immediately upon the closing of the issuer's initial public offering, and has no expiration date.
- [F2]The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001765710
Filing Metadata
- Form type
- 3
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:16 PM ET
- Size
- 7.7 KB